mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.0023 |
1 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.0011 |
1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0011 |
1 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0011 |
1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |